Models of cardiovascular surgery biobanking to facilitate translational research and precision medicine
journal contributionposted on 17.05.2022, 04:26 authored by YY Zhu, D Jackson, B Hunter, L Beattie, L Turner, BD Hambly, RW Jeremy, C Malecki, EN Robertson, Amy Li, C dos Remedios, D Richmond, C Semsarian, JF O'Sullivan, PG Bannon, S Lal
Biobanking in health care has evolved over the last few decades from simple biological sample repositories to complex and dynamic units with multi-organizational infrastructure networks and has become an essential tool for modern medical research. Cardiovascular tissue biobanking provides a unique opportunity to utilize cardiac and vascular samples for translational research into heart failure and other related pathologies. Current techniques for diagnosis, classification, and treatment monitoring of cardiac disease relies primarily on interpretation of clinical signs, imaging, and blood biomarkers. Further research at the disease source (i.e. myocardium and blood vessels) has been limited by a relative lack of access to quality human cardiac tissue and the inherent shortcomings of most animal models of heart disease. In this review, we describe a model for cardiovascular tissue biobanking and databasing, and its potential to facilitate basic and translational research. We share techniques to procure endocardial samples from patients with hypertrophic cardiomyopathy, heart failure with reduced ejection fraction, and heart failure with preserved ejection fraction, in addition to aortic disease samples. We discuss some of the issues with respect to data collection, privacy, biobank consent, and the governance of tissue biobanking. The development of tissue biobanks as described here has significant scope to improve and facilitate translational research in multi-omic fields such as genomics, transcriptomics, proteomics, and metabolomics. This research heralds an era of precision medicine, in which patients with cardiovascular pathology can be provided with optimized and personalized medical care for the treatment of their individual phenotype.
JournalESC Heart Failure
Rights Statement© 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Read the peer-reviewed publication
Science & TechnologyLife Sciences & BiomedicineCardiac & Cardiovascular SystemsCardiovascular System & CardiologyTissue biobankingTranslational researchHeart failureHypertrophic obstructive cardiomyopathyHUMAN HEARTARTIFICIAL-INTELLIGENCEGENE-EXPRESSIONPROCUREMENTCONSENSUSTRENDSAnimalsBiological Specimen BanksBiomedical ResearchGenomicsHumansPrecision MedicineTranslational Research, Biomedical